639 related articles for article (PubMed ID: 25982320)
1. Intravenous IgG (IVIG) and subcutaneous IgG (SCIG) preparations have comparable inhibitory effect on T cell activation, which is not dependent on IgG sialylation, monocytes or B cells.
Issekutz AC; Rowter D; Miescher S; Käsermann F
Clin Immunol; 2015 Oct; 160(2):123-32. PubMed ID: 25982320
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation.
MacMillan HF; Lee T; Issekutz AC
Clin Immunol; 2009 Aug; 132(2):222-33. PubMed ID: 19447680
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation of cord blood and peripheral blood monocytes by intravenous immunoglobulin.
Gille C; Dreschers S; Spring B; Tárnok A; Bocsi J; Poets CF; Orlikowsky TW
Cytometry B Clin Cytom; 2012 Jan; 82(1):26-34. PubMed ID: 21812105
[TBL] [Abstract][Full Text] [Related]
5. Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production.
Tawfik DS; Cowan KR; Walsh AM; Hamilton WS; Goldman FD
Pediatr Allergy Immunol; 2012 Feb; 23(1):88-95. PubMed ID: 21265884
[TBL] [Abstract][Full Text] [Related]
6. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells.
Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T
Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971
[TBL] [Abstract][Full Text] [Related]
7. In vitro inhibition by intravenous immunoglobulin of human T cell-dependent B cell differentiation induced by staphylococcal superantigens.
Stohl W; Elliot JE
Clin Immunol Immunopathol; 1996 May; 79(2):122-33. PubMed ID: 8620618
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of inhibitory effect of intravenous immunoglobulin on neonatal umbilical cord blood lymphocytes].
Hao YQ; Chen TX; Zhu YZ; Li QS
Zhonghua Er Ke Za Zhi; 2005 Jun; 43(6):438-43. PubMed ID: 16053731
[TBL] [Abstract][Full Text] [Related]
9. Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin).
Ruiz de Souza V; Carreno MP; Kaveri SV; Ledur A; Sadeghi H; Cavaillon JM; Kazatchkine MD; Haeffner-Cavaillon N
Eur J Immunol; 1995 May; 25(5):1267-73. PubMed ID: 7774630
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG.
Andersson UG; Björk L; Skansén-Saphir U; Andersson JP
Immunology; 1993 Jun; 79(2):211-6. PubMed ID: 8344700
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of cytokine-induced proliferation of human Natural Killer cells by intravenous immunoglobulin G.
Issekutz AC; Derfalvi B; Käsermann F; Rowter D
Clin Immunol; 2015 Dec; 161(2):373-83. PubMed ID: 26307433
[TBL] [Abstract][Full Text] [Related]
12. IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes.
Romano MF; Lamberti A; Petrella A; Bisogni R; Tassone PF; Formisano S; Venuta S; Turco MC
J Immunol; 1996 Mar; 156(6):2119-23. PubMed ID: 8690900
[TBL] [Abstract][Full Text] [Related]
13. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.
Wakim M; Alazard M; Yajima A; Speights D; Saxon A; Stiehm ER
Ann Allergy Asthma Immunol; 1998 Aug; 81(2):153-8. PubMed ID: 9723561
[TBL] [Abstract][Full Text] [Related]
14. IVIg prevents the in vitro activation of T cells by neutralizing the T cell activators.
Padet L; Bazin R
Immunol Lett; 2013 Feb; 150(1-2):54-60. PubMed ID: 23295311
[TBL] [Abstract][Full Text] [Related]
15. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
[TBL] [Abstract][Full Text] [Related]
16. Yin zi huang, an injectable multicomponent chinese herbal medicine, is a potent inhibitor of T-cell activation.
Chen X; Krakauer T; Oppenheim JJ; Howard OM
J Altern Complement Med; 2004 Jun; 10(3):519-26. PubMed ID: 15253857
[TBL] [Abstract][Full Text] [Related]
17. B cells are resistant to immunomodulation by 'IVIg-educated' dendritic cells.
Maddur MS; Hegde P; Sharma M; Kaveri SV; Bayry J
Autoimmun Rev; 2011 Dec; 11(2):154-6. PubMed ID: 21864723
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway.
Prasad NK; Papoff G; Zeuner A; Bonnin E; Kazatchkine MD; Ruberti G; Kaveri SV
J Immunol; 1998 Oct; 161(7):3781-90. PubMed ID: 9759905
[TBL] [Abstract][Full Text] [Related]
19. In vitro effects of everolimus and intravenous immunoglobulin on cell proliferation and apoptosis induction in the mixed lymphocyte reaction.
Amet N; Gacad M; Petrosyan A; Pao A; Jordan SC; Toyoda M
Transpl Immunol; 2010 Aug; 23(4):170-3. PubMed ID: 20609387
[TBL] [Abstract][Full Text] [Related]
20. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
